Table 2.
Cases of Q fever endocarditis reported in PUMCH from 2006 to 2016
| Items | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 |
|---|---|---|---|---|---|---|
| Gender | Male | Male | Male | Male | Male | Male |
| Age (years) | 41 | 22 | 61 | 54 | 55 | 58 |
| NYHA classification | 2 | 3 | 1 | 2 | N/A | 3 |
| Symptoms | Fever, cough, jaundice | Fever, cough, chest pain | Fever, erythema | Fever, arterial embolism | Fever, weight loss, cough | Fever, chills, weakness, weight loss |
| Cardiac findings | Mitral aortic valve deformity, aortic valve vegetation | Vegetations on chordae tendineae of the anterior leaflet of the mitral valve | Aortic valve thickening with vegetations | Vegetations on bioprosthetic aortic valve, mild to moderate aortic perivalvular leakage | Stenosis and Regurgitation of aortic and mitral valves. Aortic valve vegetation | Atrial perivalvular abscess and vegetation. Mitral valve regurgitation |
| Phase I IgG | 1:800 | 1:1600 | 1:>5120 | 1:3200 | >1:1600 | 1:6400 |
| Phase II IgG | 1:800 | 1:800 | 1:>5120 | 1:800 | >1:1600 | N/A |
| Antimicrobial therapy | Minocycline | Doxycycline + SMZ–TMP | Doxycycline | Minocycline + HCQ | Amikacin + vancomycin | Minocycline + HCQ |
| Operation | No | No | No | Yes, due to congestive heart failure | Yes | No |
| Follow–up (months) | 53 | 30 | 37 | 36 | 24 | 48 |
| Outcome | Cure | Cure | Cure | Bioprostheticvalvuloplasty and cure | Cure | Stable* |
*Reported to be stable upon discharge, further details unknown. NYHA: New York Heart Association; SMZ–TMP: Sulfamethoxazole–trimethoprim; HCQ: Hydroxycholoroquine; PUMCH: Peking Union Medical College Hospital; N/A: Not available.